Validity of the Danish National Registry of patients for chemotherapy reporting among colorectal cancer patients is high

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 327-334

  Lund, Jennifer L ^a   Frøslev, Trine ^a   Deleuran, Thomas ^a   Erichsen, Rune ^a   Nilsson, Tove ^a   Pedersen, Annette Nørkær ^a   Høyer, Morten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Administrative data; Chemotherapy; Colorectal cancer

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGISTRY; CLINICAL ARTICLE; COLORECTAL CANCER; DANISH NATIONAL REGISTRY OF PATIENTS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; PHARMACY; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL; VALIDITY;

EID: 84884131121     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S49773     Document Type: Article

References (20)

1. Statens Serum Institut. Cancerregisteret 2011, tal og analyse. [Cancer Registry 2011, Figures and Analysis]. Available from: http://www.ssi.dk/Sundhedsdataogit/Registre/~/media/Indhold/DK%20-%20dansk/Sundhedsdata%20og%20it/NSF/Registre/Cancerregisteret/Cancerregisteret%202011.ashx. Accessed April 22, 2013. Danish.
2. The Danish Colorectal Cancer Group. The Danish Colorectal Cancer Group Guidelines 2012. Available from: http://www.dccg.dk/retningslinjer/indeks.html. Danish. Accessed April 22, 2013.
3. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351.
4. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
5. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291: 2720-2726.
6. Ministry of Health and Prevention. Health Care in Denmark, Copenhagen, Denmark, 2008. Available from: http://www.sum.dk/Aktuelt/Publikationer//media/Filer%20-%20Publikationer_i_pdf/2008/ UK_Healthcare_in_dk/pdf.ashx.Danish.Accessed July 24, 2013.
7. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287:2398-2399.
8. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
9. Helqvist L, Erichsen R, Gammelager H, et al. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. Eur J Cancer Care (Engl). 2012;21:722-727.
10. Dobie SA, Baldwin LM, Dominitz JA, et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006;98:610-619.
11. Lund JL, Sturmer T, Harlan LC, et al. Identifying specific chemotherapeutic agents in medicare data: a validation study. Med Care. 2013;51: e27-e34.
12. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40:IV55-IV61.
13. Lund JL, Stürmer T, Sanoff HK, Brookhart A, Sandler RS, Warren JL. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients. Cancer. 2013;119:2038-2047.
14. Mack CD, Glynn RJ, Brookhart MA, et al. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf. 2013;22: 810-818.
15. Sanoff HK, Carpenter WR, Freburger J, et al. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer. 2012;118:4309-4320.
16. Sanoff HK, Carpenter WR, Martin CF, et al. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst. 2012;104:211-227.
17. Sanoff HK, Carpenter WR, Sturmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30:2624-2634.
18. National Cancer Plan, Copenhagen, Denmark: National Board of Health; 2004. Available from: http://www.sst.dk/publ/Publ2004/The_Nat_Cancer_Plan_02.pdf. Accessed July 24, 2013.
19. National Board of Health. National Cancer Plan II, Copenhagen, Denmark: National Board of Health, 2005. Copenhagen, Denmark: National Board of Health; 2004. Available from: http://www.sst.dk/publ/Publ2005/PLAN/kraeftplan2/KraeftplanII_UK/KraeftplanII_UK_med.pdf. Accessed July 24, 2013.
20. Ostenfeld EB, Froslev T, Friis S, et al. Completeness of colon and rectal cancer staging in the Danish Cancer Registry, 2004-2009. Clin Epidemiol. 2012;4 Suppl 2:33-38.